The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Clovis Oncology; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Tesaro
Travel, Accommodations, Expenses - AstraZeneca
Randomized phase II study of sapanisertib (SAP) + paclitaxel (PAC) versus PAC alone in patients (pts) with advanced, recurrent, or persistent endometrial cancer.
 
Giovanni Scambia
Speakers' Bureau - Clovis Oncology; MSD
 
Sileny N. Han
No Relationships to Disclose
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Nicoletta Colombo
Honoraria - AstraZeneca; PharmaMar; Roche/Genentech; Tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech; Takeda; Tesaro
 
Ana Oaknin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Genmab; Immunogen; PharmaMar; Roche; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Amgen (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Clovis Oncology (Inst); Eisai (Inst); Regeneron (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Francesco Raspagliesi
Speakers' Bureau - GlaxoSmithKline; Tesaro
Travel, Accommodations, Expenses - Roche
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Tesaro
Consulting or Advisory Role - Clovis Oncology; Genentech; Merck; Mersana; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - TapImmune Inc.
Other Relationship - AstraZeneca
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; ImmunoGen; MSD; Roche; Takeda; Tesaro
Research Funding - Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche
 
Andrea Jewell
No Relationships to Disclose
 
Vicky Makker
Honoraria - Eisai; Merck; Merck
Consulting or Advisory Role - ArQule; Eisai; Karyopharm Therapeutics; Merck; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Eva M. Guerra
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Merck Sharp & Dohme; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - Baxter; GlaxoSmithKline; Roche; Tesaro
 
Katherine M. Moxley
Consulting or Advisory Role - Clovis Oncology (Inst); Tessa Therapeutics (Inst)
 
Jean-Francois Baurain
No Relationships to Disclose
 
Zhenqiang Su
Employment - Takeda
 
Rachel Neuwirth
Employment - Takeda
 
Sylvie Vincent
Employment - Takeda
Stock and Other Ownership Interests - Adaptimmune; Agenus; Agios; Alkermes; Aveo; Bristol-Myers Squibb; Bristol-Myers Squibb; Celldex; cellexis; Genocea Biosciences; Gilead Sciences; HERON; Mannkind; Mereo BioPharma; Merrimack; Minerva Neurosciences; Sanofi; Verastem
Patents, Royalties, Other Intellectual Property - AVEO; Enanta
 
Farhad Sedarati
Employment - Takeda
Stock and Other Ownership Interests - Takeda
(OPTIONAL) Uncompensated Relationships - Takeda
 
Douglas V. Faller
Employment - Takeda
Leadership - Viracta Therapeutics
Stock and Other Ownership Interests - Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Viracta Therapeutics
 
Jonathan Krell
No Relationships to Disclose